HDAC inhibition increases Ewing sarcoma sensitivity to chemotherapy

被引：0
|
作者：
Smith, Kaitlyn H.
Sholler, Chloe
Gandra, Divya
McKinney, Kimberly
Dykema, Karl
Nagulapally, Abhinav
Trovillion, Erin
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-6252
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6252
引用
收藏
页数：2
相关论文
共 50 条
  • [21] RESPONSE OF OSTEOSARCOMA AND EWING SARCOMA TO CHEMOTHERAPY - IMAGING EVALUATION
    FLETCHER, BD
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1991, 157 (04) : 825 - 833
  • [22] EWING SARCOMA - EXPERIENCE WITH CYTOSTATIC CHEMOTHERAPY IN ADOLESCENTS AND ADULTS
    BINSACK, T
    SAUER, H
    ISSELS, R
    WILMANNS, W
    BLUT, 1984, 49 (03): : 265 - 265
  • [23] High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition
    Awad, Ola
    Yustein, Jason T.
    Shah, Preeti
    Gul, Naheed
    Katuri, Varalakshmi
    O'Neill, Alison
    Kong, Yali
    Brown, Milton L.
    Toretsky, Jeffrey A.
    Loeb, David M.
    PLOS ONE, 2010, 5 (11):
  • [24] Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
    Oxana Schmidt
    Nadja Nehls
    Carolin Prexler
    Kristina von Heyking
    Tanja Groll
    Katharina Pardon
    Heathcliff D. Garcia
    Tim Hensel
    Dennis Gürgen
    Anton G. Henssen
    Angelika Eggert
    Katja Steiger
    Stefan Burdach
    Günther H. S. Richter
    Journal of Experimental & Clinical Cancer Research, 40
  • [25] Inhibition of BET bromodomain proteins and the PI3K pathway in Ewing sarcoma down regulates the specific transcriptional program, inhibits tumorigenicity and increases apoptosis in Ewing sarcoma
    Hensel, T.
    Giorgi, C.
    Becker-Dettling, F.
    Calzada-Wack, J.
    Neff, F.
    Schmidt, O.
    Schafer, B. W.
    Burdach, S.
    Richter, G. H.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S48 - S48
  • [26] Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
    Schmidt, Oxana
    Nehls, Nadja
    von Heyking, Kristina
    Hensel, Tim
    Burdach, Stefan
    Richter, Gunther H.
    CANCER RESEARCH, 2018, 78 (13)
  • [27] Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
    Schmidt, Oxana
    Nehls, Nadja
    Prexler, Carolin
    von Heyking, Kristina
    Groll, Tanja
    Pardon, Katharina
    Garcia, Heathcliff D.
    Hensel, Tim
    Guergen, Dennis
    Henssen, Anton G.
    Eggert, Angelika
    Steiger, Katja
    Burdach, Stefan
    Richter, Guenther H. S.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [28] In vitro efficacy of a novel dual PARP-HDAC inhibitor in ewing sarcoma
    Truong, Sarah
    Zhai, Beibei
    Ghaidi, Fariba
    Ramos, Louise
    Joshi, Jay
    Brown, Dennis
    Sankar, Neil
    Langlands, John
    Bacha, Jeffrey
    Shen, Wang
    Sorensen, Poul
    Daugaard, Mads
    CLINICAL CANCER RESEARCH, 2022, 28 (18)
  • [29] Optimizing ATR Inhibition and Cisplatin Synergy in Ewing Sarcoma
    Ohmura, Shunya
    Gruenewald, Thomas G. P.
    CLINICAL CANCER RESEARCH, 2024, 30 (16) : 3358 - 3360
  • [30] Evaluation of LDH inhibition as a treatment strategy in Ewing sarcoma
    Heske, Christine M.
    Gibson, Anna E.
    Baumgart, Josh T.
    Yeung, Choh
    Issaq, Sameer H.
    Mendoza, A.
    Johnson, Michelle S.
    Squadrito, Guiseppe L.
    Culp, Lillian
    Darley-Usmar, Victor M.
    Neckers, Len M.
    CANCER RESEARCH, 2018, 78 (19)
12345